Tags

Type your tag names separated by a space and hit enter

Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Am J Cardiol. 2012 Jan 01; 109(1):53-9.AJ

Abstract

Published reports describe a strong association between plasma glucose levels on admission and mortality in patients who undergo primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. The aim of this study was to assess the predictive value of admission glucose levels for early and late mortality. From 2005 to 2007, 1,646 patients underwent primary percutaneous coronary intervention for ST-segment elevation myocardial infarction and were stratified according to admission plasma glucose level in category 1 (<7.8 mmol/L; n = 747), category 2 (7.8 to 11.0 mmol/L; n = 620), or category 3 (>11 mmol/L; n = 279). Event rates were estimated using the Kaplan-Meier method. A landmark survival analysis to 3-year follow-up was performed, with a landmark set at 30 days. Time-extended Cox regression was used to assess the predictive value of admission glucose levels. Furthermore, a stratified analysis was performed for known diabetes mellitus status at admission. Thirty-day mortality was 2.4% in category 1, 6% in category 2, and 22% in category 3 (p <0.01). Three-year mortality in 30-day survivors was 5.9% in category 1, 8.2% in category 2, and 7.1% in category 3 (p = 0.27). Glucose level on admission was a strong predictor of 30-day mortality: for every 1 mmol/L increase, the hazard increased by 14% (hazard ratio 1.14, 95% confidence interval 1.09 to 1.19, p <0.01) in patients without diabetes, by 12% (hazard ratio 1.12, 95% confidence interval 1.05 to 1.19, p <0.01) in those with diabetes, and by 13% (hazard ratio 1.13, 95% confidence interval 1.09 to 1.17, p <0.01) in the total cohort. After 30 days, glucose level at admission lost its predictive value. In conclusion, in patients with and those without diabetes, glucose level at admission is an independent predictor of early but not late mortality.

Authors+Show Affiliations

Academic Medical Center, Amsterdam, The Netherlands.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

21944676

Citation

Hoebers, Loes P., et al. "Predictive Value of Plasma Glucose Level On Admission for Short and Long Term Mortality in Patients With ST-elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention." The American Journal of Cardiology, vol. 109, no. 1, 2012, pp. 53-9.
Hoebers LP, Damman P, Claessen BE, et al. Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol. 2012;109(1):53-9.
Hoebers, L. P., Damman, P., Claessen, B. E., Vis, M. M., Baan, J., van Straalen, J. P., Fischer, J., Koch, K. T., Tijssen, J. G., de Winter, R. J., Piek, J. J., & Henriques, J. P. (2012). Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. The American Journal of Cardiology, 109(1), 53-9. https://doi.org/10.1016/j.amjcard.2011.07.067
Hoebers LP, et al. Predictive Value of Plasma Glucose Level On Admission for Short and Long Term Mortality in Patients With ST-elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention. Am J Cardiol. 2012 Jan 1;109(1):53-9. PubMed PMID: 21944676.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. AU - Hoebers,Loes P, AU - Damman,Peter, AU - Claessen,Bimmer E, AU - Vis,Marije M, AU - Baan,Jan,Jr AU - van Straalen,Jan P, AU - Fischer,Johan, AU - Koch,Karel T, AU - Tijssen,Jan G P, AU - de Winter,Robbert J, AU - Piek,Jan J, AU - Henriques,Jose P S, Y1 - 2011/09/23/ PY - 2011/05/18/received PY - 2011/07/29/revised PY - 2011/07/29/accepted PY - 2011/9/28/entrez PY - 2011/9/29/pubmed PY - 2012/2/9/medline SP - 53 EP - 9 JF - The American journal of cardiology JO - Am. J. Cardiol. VL - 109 IS - 1 N2 - Published reports describe a strong association between plasma glucose levels on admission and mortality in patients who undergo primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. The aim of this study was to assess the predictive value of admission glucose levels for early and late mortality. From 2005 to 2007, 1,646 patients underwent primary percutaneous coronary intervention for ST-segment elevation myocardial infarction and were stratified according to admission plasma glucose level in category 1 (<7.8 mmol/L; n = 747), category 2 (7.8 to 11.0 mmol/L; n = 620), or category 3 (>11 mmol/L; n = 279). Event rates were estimated using the Kaplan-Meier method. A landmark survival analysis to 3-year follow-up was performed, with a landmark set at 30 days. Time-extended Cox regression was used to assess the predictive value of admission glucose levels. Furthermore, a stratified analysis was performed for known diabetes mellitus status at admission. Thirty-day mortality was 2.4% in category 1, 6% in category 2, and 22% in category 3 (p <0.01). Three-year mortality in 30-day survivors was 5.9% in category 1, 8.2% in category 2, and 7.1% in category 3 (p = 0.27). Glucose level on admission was a strong predictor of 30-day mortality: for every 1 mmol/L increase, the hazard increased by 14% (hazard ratio 1.14, 95% confidence interval 1.09 to 1.19, p <0.01) in patients without diabetes, by 12% (hazard ratio 1.12, 95% confidence interval 1.05 to 1.19, p <0.01) in those with diabetes, and by 13% (hazard ratio 1.13, 95% confidence interval 1.09 to 1.17, p <0.01) in the total cohort. After 30 days, glucose level at admission lost its predictive value. In conclusion, in patients with and those without diabetes, glucose level at admission is an independent predictor of early but not late mortality. SN - 1879-1913 UR - https://www.unboundmedicine.com/medline/citation/21944676/Predictive_value_of_plasma_glucose_level_on_admission_for_short_and_long_term_mortality_in_patients_with_ST_elevation_myocardial_infarction_treated_with_primary_percutaneous_coronary_intervention_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0002-9149(11)02547-1 DB - PRIME DP - Unbound Medicine ER -